47
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T16949 |
Sucrose octaacetate
|
Others | Others |
Sucrose octaacetate 是蔗糖的乙酰化衍生物,具有强烈的苦味,可用作苦味替代品。它可用作食品添加剂,还可用作粘合剂和增塑剂。它也可用作软模板,以合成聚苯胺纳米纤维。它还用于许多农药,杀虫剂和其他有毒产品中,以防止意外中毒。 | |||
T5286 |
Glycylglycine
Glycyl-glycine,Glycine dipeptide,Diglycocoll,Diglycine,Gly-gly,双甘肽,N-Glycylglycine |
Others; Endogenous Metabolite | Metabolism; Others |
Glycylglycine (Diglycine) 是一种简单的多肽,能够作为谷氨酰胺 (gamma-glutamyl) 的受体。 | |||
T16703 |
Quarfloxin
CX-3543 |
DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
Quarfloxin (CX-3543) 是一种氟喹诺酮衍生物,具有抗肿瘤活性,可靶向抑制RNA pol I 的活性,在神经母细胞瘤细胞中的 IC50 值在纳摩尔范围内。它破坏核糖体 DNA 模板中核仁蛋白和 G-四链体 DNA 结构之间的相互作用。 | |||
TNU1075 |
2-Iodo-2’-deoxyadenosine
|
||
2-Iodo-2'-deoxyadenosine is a Nucleoside Derivative - Halo-nucleoside; 2-Modified purine nucleoside; Scaffold and Template. | |||
TNU1278 |
2,6-Dichloro-2',3',5'-triacetyl-purine riboside
|
||
2,6-Dichloro-2',3',5'-triacetyl-purine riboside is a Nucleoside Derivative - Halo-nucleoside; Scaffold and Template. | |||
TNU0275 |
8-Aza-7-bromo-7-deazaguanosine
|
||
8-Aza-7-bromo-7-deazaguanosine is a Nucleoside Derivative - 7-Deaza-8-aza-purine nucleoside; Halo-nucleoside; Scaffold and Template. | |||
TNU1013 |
6-Chloro-7-fluoro-7-deazapurine
|
||
6-Chloro-7-fluoro-7-deazapurine bolongs toIntermediates and Building Blocks - Nucleoside Base; Multi-functional; Heterocyclic Compounds - Purine; Scaffold and Template. | |||
TNU1016 |
6-Bromopyrazolo[3,4-d]pyrimidin-4(5H)-one
|
||
6-Bromopyrazolo[3,4-d]pyrimidin-4(5H)-one bolongs toIntermediates and Building Blocks - Nucleoside Base; Multi-functional; Heterocyclic Compounds - Purine; Scaffold and Template. | |||
TNU0879 |
6-Chloro-2-iodo-9-(2,3,5-tri-O-acetyl)-beta-D-ribofuranosyl-9H-purine
|
||
6-Chloro-2-iodo-9-(2,3,5-tri-O-acetyl)-beta-D-ribofuranosyl-9H-purine is a Nucleoside Derivative - Halo-nucleoside; Scaffold and Template. | |||
TNU1015 |
4-Amino-6-bromo-5-cyano-7H-pyrrolo[2,3-d]pyrimidine
|
||
4-Amino-6-bromo-5-cyano-7H-pyrrolo[2,3-d]pyrimidine bolongs toIntermediates and Building Blocks - Nucleoside Base; Multi-functional; Heterocyclic Compounds - Purine; Scaffold and Template. | |||
TNU0870 |
5-(2-Hydroxyethyl)uracil
|
||
5-(2-Hydroxyethyl)uracil bolongs toIntermediates and Building Blocks - Nucleoside base, Nucleophile; Heterocylic Compounds - Pyrimidine; Scaffold and Template. | |||
TNU0877 |
N-(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-2,2-dimethyl propanamide
|
||
N-(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-2,2-dimethyl propanamide belongs to Heterocyclic Compounds - Purine; Intermediates and Building Blocks - Nucleoside base, Electrophile; Scaffold and Template. | |||
TNU1018 |
6-Amino-4-chloropyrazolo[3,4-d]pyrimidine
|
||
6-Amino-4-chloropyrazolo[3,4-d]pyrimidine bolongs toIntermediates and Building Blocks - Nucleoside Base; Multi-functional; Heterocyclic Compounds - Purine; Scaffold and Template. | |||
TNU1068 |
4-Chloro-7-[(5-O-t-butyldimethylsilyl)-2,3-O-isopropyli-dene-β-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidine
|
||
Nucleoside Derivatives - 7-Deaza-purine nucleoside; Halo-nucleoside; Scaffolds and Template | |||
TNU1017 |
3,6-Dibromopyrazolo[3,4-d]pyrimidin-4(5H)-one
|
||
3,6-Dibromopyrazolo[3,4-d]pyrimidin-4(5H)-one bolongs toIntermediates and Building Blocks - Nucleoside Base; Multi-functional; Heterocyclic Compounds - Purine; Scaffold and Template. | |||
TNU0760 |
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-2-chloro-6-(thiophen-3-yl)purine
|
||
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-2-chloro-6-(thiophen-3-yl)purine is a Nucleoside Derivative - Fluoro-modified nucleoside, 6-Modified purine nucleoside, Halo-nucleoside, 3'-Modified nucleoside; Scaffold and Template. | |||
TNU0121 |
5-Pyrrolidinomethyluridine
|
||
5-Pyrrolidinomethyluridine is a Nucleoside Derivative - 5-Modified pyrimidine nucleoside; Scaffold and Template. | |||
TNU1020 |
6-Amino-3-iodo-4-methoxy-1H-pyrazolo[3,4-d]pyrimidine
|
||
6-Amino-3-iodo-4-methoxy-1H-pyrazolo[3,4-d]pyrimidine bolongs toIntermediates and Building Blocks - Nucleoside Base; Multi-functional; Heterocyclic Compounds - Purine; Scaffold and Template. | |||
TNU1069 |
4-Chloro-7-(2,3-O-isopropylidene-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine
|
||
Nucleoside Derivatives - 7-Deaza-purine nucleoside; Halo-nucleoside, Protected nucleosides with NH2/OH open; Scaffolds and Template | |||
TNU1074 |
2-Bromo-2’-deoxyadenosine
|
||
2-Bromo-2'-deoxyadenosine is a Nucleoside Derivative - Halo-nucleoside; 2-Modified purine nucleoside; Scaffold and Template. | |||
TNU0632 |
5’-O-(p-Toluoyl)-2’-O-acetyl-3’-deoxy-3’-fluoro-6-chloroinosine
|
||
5'-O-(p-Toluoyl)-2'-O-acetyl-3'-deoxy-3'-fluoro-6-chloroinosine is a Nucleoside Derivative - Fluoro-modified nucleoside, Halo-nucleoside, 3'-Modified nucleoside; Scaffold and Template. | |||
TNU1034 |
4-Amino-6-bromo-5-cyano-1-(beta-D-ribofuranosyl)-7H-pyrrolo[2.3-d]pyrimidine
|
||
4-Amino-6-bromo-5-cyano-1-(beta-D-ribofuranosyl)-7H-pyrrolo[2.3-d]pyrimidine is a Nucleoside Derivative - 7-Deaza-purine nucleoside, 8-Modified-purine nucleoside, Halo-nucleoside; Scaffold and Template. | |||
TNU0872 |
5-(3-Hydroxypropyl)uracil
|
||
5-(3-Hydroxypropyl)uracil bolongs toIntermediates and Building Blocks - Nucleoside base, Nucleophile; Heterocylic Compounds - Pyrimidine; Scaffold and Template. | |||
TNU0871 |
5-(2-Hydroxyethyl)-2-thiouracil
|
||
5-(2-Hydroxyethyl)-2-thiouracil bolongs toIntermediates and Building Blocks - Nucleoside base, Nucleophile; Heterocylic Compounds - Pyrimidine; Scaffold and Template. | |||
TNU1279 |
5-(2-Hyroxyethyl)-2’,3’-di-O-toluoyl-2’-deoxyuridine
|
||
5-(2-Hyroxyethyl)-2',3'-di-O-toluoyl-2'-deoxyuridine is a Nucleoside Derivative - 5-Modified pyrimidine nucleoside; Scaffold and Template. | |||
TNU1073 |
6-Chloro-2-bromo-9-(2,3,5-tri-O-acetyl)-beta-D-ribofuranosyl-9H-purine
|
||
6-Chloro-2-bromo-9-(2,3,5-tri-O-acetyl)-beta-D-ribofuranosyl-9H-purine is a Nucleoside Derivative - Halo-nucleoside; Scaffold and Template. | |||
TNU1019 |
6-Amino-4-methoxypyrazolo[3,4-d]pyrimidine
|
||
6-Amino-4-methoxypyrazolo[3,4-d]pyrimidine bolongs toIntermediates and Building Blocks - Nucleoside Base; Multi-functional; Heterocyclic Compounds - Purine; Scaffold and Template. | |||
TNU0983 |
2-Amino-6-chloro-9-(3-deoxy-beta-D-ribofuanosyl)-9H-purine
|
||
2-Amino-6-chloro-9-(3-deoxy-beta-D-ribofuanosyl)-9H-purine is a Nucleoside Derivative - 3'-Deoxy nucleoside, Halo-nucleoside; Scaffold and Template. | |||
TNU0981 |
9-(2’-O-Acetyl-5’-O-benzoyl-3’-deoxy-beta-D-ribofuranosyl)-6-chloropurine
|
||
9-(2'-O-Acetyl-5'-O-benzoyl-3'-deoxy-beta-D-ribofuranosyl)-6-chloropurine is a Nucleoside Derivative - 3'-Deoxy nucleoside, Halo-nucleoside; Scaffold and Template. | |||
T25287 |
Dansyllysine
Dns-lysine |
||
Dansyllysine is utilized to study binding conformations of drugs to human serum albumin and is utilized as a template molecule to form molecularly imprinted monolayers (MIMs) useful to produce optical biosensor recognition elements. | |||
TNU0878 |
N-(4-Chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-2,2-dimethyl propanamide
|
||
N-(4-Chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-2,2-dimethyl propanamide belongs to Heterocyclic Compounds - Purine; Intermediates and Building Blocks - Nucleoside base, Electrophile; Scaffold and Template. | |||
TNU0982 |
2-Amino-6-chloro-9-(3-deoxy-2-O-acetyl-5-O-benzoyl-beta-D-ribofuanosyl)-9H-purine
|
||
2-Amino-6-chloro-9-(3-deoxy-2-O-acetyl-5-O-benzoyl-beta-D-ribofuanosyl)-9H-purine is a Nucleoside Derivative - 3'-Deoxy nucleoside, Halo-nucleoside; Scaffold and Template. | |||
TNU0090 |
2-Amino-6-chloro-9-(3-deoxy-3-fluoro-beta-D-ribofuranosyl)-9H-purine
|
||
2-Amino-6-chloro-9-(3-deoxy-3-fluoro-beta-D-ribofuranosyl)-9H-purine is a Nucleoside Derivative - Fluoro-modified nucleoside, Halo-nucleoside, 3'-Modified nucleoside; Scaffold and Template. | |||
TNU0088 |
2-Chloro-6-(furan-2-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside
|
||
2-Chloro-6-(furan-2-yl)purine-beta-D-(3'-deoxy-3'-fluoro)riboside is a Nucleoside Derivative - Fluoro-modified nucleoside, 6-Modified purine nucleoside, Halo-nucleoside, 3'-Modified nucleoside; Scaffold and Template. | |||
TNU0103 |
4-Amino-5-iodo-7-(2-b-C-methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine
|
||
4-Amino-5-iodo-7-(2-b-C-methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine is a Nucleoside Derivative - 7-Deaza-purine nucleoside; 2'-Modified nucleoside; Halo-nucleoside; Scaffold and Template. | |||
TNU0102 |
4-Chloro-7-(2-b-C-methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d] pyrimidine
|
||
4-Chloro-7-(2-b-C-methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d] pyrimidine is a Nucleoside Derivative - 7-Deaza-purine nucleoside; 2'-Modified nucleoside; Halo-nucleoside; Scaffold and Template. | |||
T24919 |
UBP714
UBP 714,UBP-714 |
||
UBP714 is a derivative of the NMDA receptor negative allosteric modulator UBP608. It also enhanced NMDAR mediated field EPSPs in the CA1 region of the hippocampus. UBP714 is a novel template for the development of potent and subunit selective NMDAR potent | |||
TNU1035 |
3,6-Dibromo-1,5-dihydro-1-(2,3,5-tri-O-benzoyl-b-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one
|
||
3,6-Dibromo-1,5-dihydro-1-(2,3,5-tri-O-benzoyl-b-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one is a Nucleoside Derivative - 7-Deaza-8-aza-purine nucleoside; Halo-nucleoside; Scaffold and Template. | |||
TNU1033 |
4-Amino-6-bromo-5-cyano-1-(2,3,5-tri-O-benzoyl-b-D-ribofuranosyl)-7H-pyrrolo[2.3-d]pyrimidine
|
||
4-Amino-6-bromo-5-cyano-1-(2,3,5-tri-O-benzoyl-b-D-ribofuranosyl)-7H-pyrrolo[2.3-d]pyrimidine is a Nucleoside Derivative - 7-Deaza-purine nucleoside, 8-Modified-purine nucleoside, Halo-nucleoside; Scaffold and Template. | |||
T78736 |
D3R ligand 1
|
Dopamine Receptor | GPCR/G Protein; Neuroscience |
D3R ligand 1 (compound 23b) 是针对多巴胺受体D3R具有高效选择性的配体,拥有66 nM的Ki值,且包含THPB模板。此外,D3R ligand 1 同时作为基于G蛋白及β-arrestin信号传导路径的拮抗剂。 | |||
T61886 |
HBV-IN-16
|
||
HBV-IN-16 是一种有效的共价闭合环状 DNA (cccDNA) 抑制剂。cccDNA 作为病毒 RNA 转录和随后病毒 DNA 生成的模板。HBV-IN-16 是一种喹啉衍生物。HBV-IN-16 具有研究 HBV 感染的潜力 。 | |||
T82916 |
BChE-IN-20
|
||
BChE-IN-20(compound 7c)作为一种BChE选择性抑制剂显示出高效性,其对eqBChE的IC50为105 nM,对hBChE的IC50为2.3 nM。同时,BChE-IN-20对P糖蛋白的IC50值为0.27 μM。此化合物为BChE选择性配体的设计与开发,包括抑制剂与荧光探针,提供了一个有潜力的模板。 | |||
T81422 |
Pomalidomid-C6-PEG3-butyl-N3
|
PROTACs | PROTAC |
Pomalidomid-C6-PEG3-butyl-N3为具有叠氮基的点击化学试剂,同时作为交联剂-E3连接酶配体偶联物,它在PROTAC领域用于点击反应蛋白降解剂构建块,以及靶向蛋白降解剂合成的模板。 | |||
T83123 |
Amyloid β-Protein (3-42)
|
||
Amyloid β-Protein (3-42) 为Pyr肽前体, 其焦谷氨酸修饰的形式 Aβ (pEAβ) (3-42) 构成阿尔茨海默病淀粉样斑块的关键。pEAβ (3-42) 能促进 Aβ(1-42) 聚集,并且 Aβ(1-42) 显著延缓pEAβ(3-42) 的初级及次级成核过程。 | |||
T35693 |
N-(2-Azidoethyl)betulonamide
|
||
N-(2-Azidoethyl)betulonamide is a pentacyclic triterpenoid, a derivative of betulonic acid , and an intermediate in the synthesis of betulonic acid derivatives within vitrocancer cell cytotoxicity.1 1.Suman, P., Patel, A., Solano, L., et al.Synthesis and cytotoxicity of Baylis-Hillman template derived betulinic acid-triazole conjugatesTetrahedron73(29)4214-4226(2017) | |||
T35658 |
3'-Deoxyuridine-5'-triphosphate trisodium
|
||
3'-Deoxyuridine-5'-triphosphate trisodium (3'-dUTP trisodium) is a nucleotide analogue that inhibits DNA-dependent RNA polymerases I and II. 3'-Deoxyuridine-5'-triphosphate trisodium strongly and competitively inhibits the incorporations of UTP into RNA with a Ki value of 2.0 μM[1]. 3'-Deoxyuridine-5'-triphosphate (3'-dUTP) is synthesized starting from cordycepin in good yield. 3'-Deoxyuridine-5'-triphosphate strongly and competitively inhibits the incorporations of UTP into RNA by the RNA polym... | |||
T35657 |
3'-Deoxyuridine-5'-triphosphate
|
||
3'-Deoxyuridine-5'-triphosphate (3'-dUTP) is a nucleotide analogue that inhibits DNA-dependent RNA polymerases I and II. 3'-Deoxyuridine-5'-triphosphate strongly and competitively inhibits the incorporations of UTP into RNA with a Ki value of 2.0 μM[1]. 3'-Deoxyuridine-5'-triphosphate (3'-dUTP) is synthesized starting from cordycepin in good yield. 3'-Deoxyuridine-5'-triphosphate strongly and competitively inhibits the incorporations of UTP into RNA by the RNA polymerases. 3'-Deoxyuridine-5'-tri... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T13592 |
Calf thymus DNA
DNA from calf thymus, Thymonucleic acid |
DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
Calf thymus DNA (DNA from calf thymus, Thymonucleic acid) 是一种从牛胸腺中提取出来的高质量双链模板DNA,可广泛应用于DNA 结合抗癌剂和调节DNA 结构和功能的DNA 结合剂的研究。 | |||
TJS0311 |
Ethyl 3-coumarincarboxylate
3-Ethoxycarbonylcoumarin,香豆素-3-羧酸乙酯,香豆素-3-羧酸乙素,Ethyl 2-Oxo-2H-Chromene-3-Carboxylate,Ethyl coumarin-3-carboxylate,3-Carbethoxycoumarin |
Others | Others |
Ethyl coumarin-3-carboxylate 是香豆素衍生物。它可作为一种伪模板,制备能够特异性识别黄曲霉毒素的分子印迹聚合物 (MIP)。 |